Use of inotropes and vasopressor agents in critically ill patients

被引：111

作者：

Bangash, Mansoor N. ^{[1
]}

Kong, Ming-Li ^{[1
]}

Pearse, Rupert M. ^{[1
]}

机构：

[1] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London, England

来源：

BRITISH JOURNAL OF PHARMACOLOGY | 2012年 / 165卷 / 07期

关键词：

inotrope; vasopressor; critical illness; haemodynamic shock; CONTRAST-INDUCED NEPHROPATHY; PULMONARY-ARTERY CATHETERS; ORIENTED HEMODYNAMIC THERAPY; MAXIMIZING OXYGEN DELIVERY; BETA-ADRENERGIC RECEPTORS; STANDARD-DOSE EPINEPHRINE; RANDOMIZED CLINICAL-TRIAL; GOAL-DIRECTED THERAPY; TUMOR-NECROSIS-FACTOR; REGIONAL BLOOD-FLOW;

D O I：

10.1111/j.1476-5381.2011.01588.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Inotropes and vasopressors are biologically and clinically important compounds that originate from different pharmacological groups and act at some of the most fundamental receptor and signal transduction systems in the body. More than 20 such agents are in common clinical use, yet few reviews of their pharmacology exist outside of physiology and pharmacology textbooks. Despite widespread use in critically ill patients, understanding of the clinical effects of these drugs in pathological states is poor. The purpose of this article is to describe the pharmacology and clinical applications of inotropic and vasopressor agents in critically ill patients.

引用

页码：2015 / 2033

页数：19

共 50 条

[1] ENTERAL VASOPRESSOR USE IN CRITICALLY ILL TRAUMA PATIENTS
Delic, Justin
Chau, Terence
Colosimo, Christina
Igneri, Lauren
Solomon, Diana
Wang, Ju-Lin
[J]. CRITICAL CARE MEDICINE, 2023, 51 (01) : 646 - 646
[2] EFFECT OF KETAMINE ON VASOPRESSOR USE AND HEMODYNAMIC PARAMETERS IN CRITICALLY ILL PATIENTS
Radosevich, John
Tafoya, Christine
Patanwala, Asad
[J]. CRITICAL CARE MEDICINE, 2016, 44 (12)
[3] THE USE OF SEDATIVE AGENTS IN CRITICALLY ILL PATIENTS
BURNS, AM
SHELLY, MP
PARK, GR
[J]. DRUGS, 1992, 43 (04) : 507 - 515
[4] Vasopressor therapy in critically ill patients with shock
Russell, James A.
[J]. INTENSIVE CARE MEDICINE, 2019, 45 (11) : 1503 - 1517
[5] Vasopressor therapy in critically ill patients with shock
James A. Russell
[J]. Intensive Care Medicine, 2019, 45 : 1503 - 1517
[6] Effects of vasopressor agents on the development of pressure ulcers in critically ill patients: a systematic review
McEvoy, Natalie
Patton, Declan
Avsar, Pinar
Curley, Ger
Kearney, Cathal
Clarke, Jennifer
Moore, Zena
[J]. JOURNAL OF WOUND CARE, 2022, 31 (03) : 266 - 277
[7] Neonatal Blood Pressure Support: The Use of Inotropes, Lusitropes, and Other Vasopressor Agents
Noori, Shahab
Seri, Istvan
[J]. CLINICS IN PERINATOLOGY, 2012, 39 (01) : 221 - +
[8] Peripheral Inotropes in Critically Ill Children: Is It Safe?
Mooli, Ravi K.
Sadasivam, Kalaimaran
[J]. GLOBAL PEDIATRIC HEALTH, 2021, 8
[9] Vasopressor use in 41 critically ill cats (2007-2016)
Licht, Nikki
Rozanski, Elizabeth A.
Rush, John E.
[J]. CANADIAN VETERINARY JOURNAL-REVUE VETERINAIRE CANADIENNE, 2018, 59 (11): : 1175 - 1180
[10] Hemostatic Agents in Critically Ill Patients
Das, Saurabh Kumar
Reddy, Maheeja Maddi
Ray, Sumit
[J]. INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2019, 23 : S226 - S229

← 1 2 3 4 5 →